AlphaGrep UK’s Medtronic MDT Stock Holding History

AlphaGrep UK’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$288K	Buy	3,342 +179	+6%	+$15.8K	0.09%	508
2026 Q2	$247K	Buy	+3,163	New	+$255K	0.07%	592
2026 Q1	–	Sell	-2,765	Closed	-$266K	–	875
2025 Q4	$266K	Buy	+2,765	New	+$269K	0.09%	498

Other funds holding MDT

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

AlphaGrep UK's MDT Position: Q3 2026 in Review

AlphaGrep UK increased its Medtronic (MDT) stake by 5.7% in Q3 2026, buying an estimated $15.8K and bringing the position to 3,342 shares worth $288K. The position accounts for 0.09% of the portfolio, ranked #508.

AlphaGrep UK first reported a position in MDT in Q4 2025 and has held it in 3 quarters since. 1,900 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

AlphaGrep UK held 3,342 shares of Medtronic worth $288K as of Q3 2026.
AlphaGrep UK bought 179 Medtronic shares in Q3 2026, an estimated $15.8K.
Medtronic made up 0.09% of AlphaGrep UK's portfolio in Q3 2026, its #508 holding.
AlphaGrep UK first reported a position in Medtronic in Q4 2025 and has held it in 3 quarters since.
1,900 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on AlphaGrep UK's 13F filing for Q3 2026, filed 12 Nov 2026.